Cargando…

The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy

As the third major reason of mortality related to cancer in the world, liver cancer is also the fifth most frequent cancer. Unluckily, a majority of patients succumb and relapse though many progresses have been made in detection and therapy of liver cancer. It has been put forward that in liver canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yanhong, Lin, Mei, Jiang, Xingmao, Ye, Jun, Guo, Ting, Shi, Yujuan, Bian, Xuefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551471/
https://www.ncbi.nlm.nih.gov/pubmed/28819584
http://dx.doi.org/10.1155/2017/5108653
_version_ 1783256312727994368
author Xiao, Yanhong
Lin, Mei
Jiang, Xingmao
Ye, Jun
Guo, Ting
Shi, Yujuan
Bian, Xuefeng
author_facet Xiao, Yanhong
Lin, Mei
Jiang, Xingmao
Ye, Jun
Guo, Ting
Shi, Yujuan
Bian, Xuefeng
author_sort Xiao, Yanhong
collection PubMed
description As the third major reason of mortality related to cancer in the world, liver cancer is also the fifth most frequent cancer. Unluckily, a majority of patients succumb and relapse though many progresses have been made in detection and therapy of liver cancer. It has been put forward that in liver cancer, cancer stem cells (CSCs) hold main responsibility for the formation, invasion, metastasis, and recurrence of tumor. Strategies that are intended to target liver CSCs are playing a more and more significant role in supervising the development of liver cancer treatment and assessing new therapeutic methods. Herein, a brief review about molecule markers, signal pathways, separation, and treatment on liver cancer stem cells (LCSCs) is provided in this paper.
format Online
Article
Text
id pubmed-5551471
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-55514712017-08-17 The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy Xiao, Yanhong Lin, Mei Jiang, Xingmao Ye, Jun Guo, Ting Shi, Yujuan Bian, Xuefeng Anal Cell Pathol (Amst) Review Article As the third major reason of mortality related to cancer in the world, liver cancer is also the fifth most frequent cancer. Unluckily, a majority of patients succumb and relapse though many progresses have been made in detection and therapy of liver cancer. It has been put forward that in liver cancer, cancer stem cells (CSCs) hold main responsibility for the formation, invasion, metastasis, and recurrence of tumor. Strategies that are intended to target liver CSCs are playing a more and more significant role in supervising the development of liver cancer treatment and assessing new therapeutic methods. Herein, a brief review about molecule markers, signal pathways, separation, and treatment on liver cancer stem cells (LCSCs) is provided in this paper. Hindawi 2017 2017-07-27 /pmc/articles/PMC5551471/ /pubmed/28819584 http://dx.doi.org/10.1155/2017/5108653 Text en Copyright © 2017 Yanhong Xiao et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Xiao, Yanhong
Lin, Mei
Jiang, Xingmao
Ye, Jun
Guo, Ting
Shi, Yujuan
Bian, Xuefeng
The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy
title The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy
title_full The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy
title_fullStr The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy
title_full_unstemmed The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy
title_short The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy
title_sort recent advances on liver cancer stem cells: biomarkers, separation, and therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551471/
https://www.ncbi.nlm.nih.gov/pubmed/28819584
http://dx.doi.org/10.1155/2017/5108653
work_keys_str_mv AT xiaoyanhong therecentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT linmei therecentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT jiangxingmao therecentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT yejun therecentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT guoting therecentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT shiyujuan therecentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT bianxuefeng therecentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT xiaoyanhong recentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT linmei recentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT jiangxingmao recentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT yejun recentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT guoting recentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT shiyujuan recentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy
AT bianxuefeng recentadvancesonlivercancerstemcellsbiomarkersseparationandtherapy